Manuka Honey Has the Potential to Reduce Breast Cancer Tumor Growth, According to a New Study
UCLA researchers published a study showing that Manuka honey was helpful "for estrogen receptor (ER)-positive breast cancer" and has the potential to be an alternative option for breast cancer ...
Columbia Missourian3h
FDA approves self-collection HPV tests as an alternative to Pap smears
The FDA has approved two new self-collection HPV tests as an option for cervical cancer screening in a health care setting.
Cure Today23h
FDA Approves MI Cancer Seek as Companion Diagnostic for Adult and Pediatric Patients With Cancer
The test identifies patients for targeted therapies in breast, colorectal ... may benefit from treatment with targeted therapies. MI Cancer Seek™ has received approval from the Food and Drug ...
News Medical1d
Cleveland Clinic presents new findings on triple-negative breast cancer vaccine
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
MarketWatch1d
Autolus Therapeutics Gets FDA Approval for Cancer Treatment
Autolus Therapeutics said it received Food and Drug Administration approval of its treatment of acute lymphoblastic leukemia, or ALL, an aggressive blood and bone marrow cancer, for certain patients.
MedPage Today1d
FDA Panel Backs Cryoablation in Early Breast Cancer as Alternative to Surgery
An FDA panel on Thursday endorsed a cryoablation system as an alternative to surgery for some early breast cancer patients.
Single Mom Told She Had 4 Months to Live — 7 Years Ago — Still Travels with Her Kids Thanks to New Trial Drug (Exclusive)
A trial drug has kept Desiree Dufour's breast cancer at bay — and now, the medication has been approved by the FDA. She has ...
IceCure's ProSense System Gets FDA Panel's Favorable Vote For Low Risk Breast Cancer Treatment
(RTTNews) - IceCure Medical Ltd. (ICCM), Friday announced that the U.S. Food and Drug Administration's Advisory panel has voted in favor of the company's ProSense technology intended for early-stage ...
Cofactor’s cancer biomarker test outshines standard ICI predictive tests
The test improved prediction of patient benefit from anti-PD-1 immune checkpoint inhibitors (ICIs) as a monotherapy and with ...
Le Lézard2d
FDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer
IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...
CBC Online 1380 KCIM2d
FDA seeks to pull common but ineffective OTC cold medicine ingredient off the market
The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the common ingredient phenylephrine off ...
Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update
NEW HAVEN, Conn., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today ...